Design, synthesis, and preliminary in vitro screening of novel tolmetin hydrazones against colon cancer


Gokoglan E., ATLIHAN TURANLI İ., ÖZEN A. S., MEGA TİBER P., Yilmaz O., Kucukguzel S. G.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol.142, 2027 (SCI-Expanded, Scopus)

  • Publication Type: Article / Article
  • Volume: 142
  • Publication Date: 2027
  • Doi Number: 10.1016/j.bmcl.2026.130791
  • Journal Name: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, Chemical Abstracts Core, Chimica, EMBASE, MEDLINE, Academic Search Ultimate (EBSCO)
  • Istanbul University Affiliated: Yes

Abstract

The present study describes the design and synthesis of twenty novel tolmetin-hydrazones (3a-t). The structures of the synthesized compounds were elucidated using FT-IR, 1 H NMR, 13 C NMR, and HR-MS (ESI + ) spectroscopy techniques. The cytotoxic potential of all synthesized compounds was evaluated against HCT-116 human colon cancer cells and CCD-18Co normal colon fibroblasts using the CCK-8 colorimetric assay. Based on their IC 50 and selectivity index (SI) values, 2-[1-methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]-N '-(thiophen-2-ylmethylene) acetohydrazide (3h) (IC 50 = 10.93 +/- 0.07 mu M / SI = 4.01) and N '-(2,3-dichlorobenzylidene)-2-[1-methyl-5-(4methylbenzoyl)-1H-pyrrol-2-yl] acetohydrazide (3q) (IC 50 = 21.41 +/- 0.13 mu M / SI = 2.76) were selected as the most active compounds for further mechanistic investigations. To elucidate the underlying cytotoxic mechanisms, mitochondrial membrane potential (MMP) assessment via JC-1 staining, apoptosis detection through Annexin V/PI double staining, and quantitative evaluation of COX-2 enzyme activity and PGE2 levels were performed on HCT-116 cells. Compound 3h selectively induced mitochondrial membrane potential depolarization, triggered apoptosis, exhibited dose-dependent COX-2 inhibition, and decreased prostaglandin levels. Furthermore, detailed molecular docking simulations of all compounds were performed against human COX-1 (PDB ID: 6Y3C) and COX-2 (PDB ID: 5KIR) enzymes to calculate their binding energies and identify the structural basis of their selectivity. In silico analysis revealed favorable binding orientations for compound 3h (- 10.1 kcal/mol), including hydrogen-bonding interactions with key active-site and gating residues such as HIS90. Collectively, compound 3h exhibits selective anticancer activity and represents a promising hit compound for the development of COX-2-targeted anticancer agents.